Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)

Safe and effective DNA delivery systems are required to enable or enhance clinical strategies and research involving gene therapy and DNA vaccinations. To address this delivery problem, a series of charge-altering releasable transporters (CARTs) with varied lipid content were prepared and evaluated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomacromolecules 2018-05, Vol.19 (7)
Hauptverfasser: Benner, Nancy L., Near, Katherine E., Bachmann, Michael H., Contag, Christopher H., Waymouth, Robert M., Wender, Paul A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Biomacromolecules
container_volume 19
creator Benner, Nancy L.
Near, Katherine E.
Bachmann, Michael H.
Contag, Christopher H.
Waymouth, Robert M.
Wender, Paul A.
description Safe and effective DNA delivery systems are required to enable or enhance clinical strategies and research involving gene therapy and DNA vaccinations. To address this delivery problem, a series of charge-altering releasable transporters (CARTs) with varied lipid content were prepared and evaluated for plasmid DNA (pDNA) delivery into cultured cells. These lipid-modified CART co-oligomers were synthesized in only two steps via sequential organocatalytic ring-opening polymerization of lipid-containing cyclic carbonate monomers and morpholinone monomers. Lipid variations of the CARTs substantially impacted the delivery efficiency of pDNA, with oleyl- and linoleyl-based CARTs showing enhanced performance relative to the commercial transfection agent Lipofectamine 2000 (L2000). The best-performing oleyl CART was carried forward to study stable luciferase transfection with a Sleeping Beauty (SB) transposon system. The oleyl CART outperformed the L2000 positive control with respect to stable transfection efficiency. CART-pDNA complexes represent a new DNA delivery system for research and clinical applications.
format Article
fullrecord <record><control><sourceid>osti</sourceid><recordid>TN_cdi_osti_scitechconnect_1594175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1594175</sourcerecordid><originalsourceid>FETCH-osti_scitechconnect_15941753</originalsourceid><addsrcrecordid>eNqNissKwjAQRYMo-PyH4EoXgdY2li5LVVyoi9K9pOmoIyGRTBT8ex_4Aa7O5dzTYYNYLpYiXUaL7ndLkWV51mdDomsURXmSygFTm7vVAZ1Vhq8OBV-BwQf4J19b1RhoefPkO7xhK_auxRO-TXlR_gyiMAE82jOvwICiT81rryzdnH8_xGdlUdU0H7PeSRmCyY8jNt2s63IrHAU8ksYA-qKdtaDDMZZ5Gmcy-St6ASNWRTY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)</title><source>ACS Publications</source><creator>Benner, Nancy L. ; Near, Katherine E. ; Bachmann, Michael H. ; Contag, Christopher H. ; Waymouth, Robert M. ; Wender, Paul A.</creator><creatorcontrib>Benner, Nancy L. ; Near, Katherine E. ; Bachmann, Michael H. ; Contag, Christopher H. ; Waymouth, Robert M. ; Wender, Paul A. ; Stanford Univ., CA (United States)</creatorcontrib><description>Safe and effective DNA delivery systems are required to enable or enhance clinical strategies and research involving gene therapy and DNA vaccinations. To address this delivery problem, a series of charge-altering releasable transporters (CARTs) with varied lipid content were prepared and evaluated for plasmid DNA (pDNA) delivery into cultured cells. These lipid-modified CART co-oligomers were synthesized in only two steps via sequential organocatalytic ring-opening polymerization of lipid-containing cyclic carbonate monomers and morpholinone monomers. Lipid variations of the CARTs substantially impacted the delivery efficiency of pDNA, with oleyl- and linoleyl-based CARTs showing enhanced performance relative to the commercial transfection agent Lipofectamine 2000 (L2000). The best-performing oleyl CART was carried forward to study stable luciferase transfection with a Sleeping Beauty (SB) transposon system. The oleyl CART outperformed the L2000 positive control with respect to stable transfection efficiency. CART-pDNA complexes represent a new DNA delivery system for research and clinical applications.</description><identifier>ISSN: 1525-7797</identifier><identifier>EISSN: 1526-4602</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>BASIC BIOLOGICAL SCIENCES</subject><ispartof>Biomacromolecules, 2018-05, Vol.19 (7)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000000163192829 ; 0000000198629509</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882</link.rule.ids><backlink>$$Uhttps://www.osti.gov/servlets/purl/1594175$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Benner, Nancy L.</creatorcontrib><creatorcontrib>Near, Katherine E.</creatorcontrib><creatorcontrib>Bachmann, Michael H.</creatorcontrib><creatorcontrib>Contag, Christopher H.</creatorcontrib><creatorcontrib>Waymouth, Robert M.</creatorcontrib><creatorcontrib>Wender, Paul A.</creatorcontrib><creatorcontrib>Stanford Univ., CA (United States)</creatorcontrib><title>Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)</title><title>Biomacromolecules</title><description>Safe and effective DNA delivery systems are required to enable or enhance clinical strategies and research involving gene therapy and DNA vaccinations. To address this delivery problem, a series of charge-altering releasable transporters (CARTs) with varied lipid content were prepared and evaluated for plasmid DNA (pDNA) delivery into cultured cells. These lipid-modified CART co-oligomers were synthesized in only two steps via sequential organocatalytic ring-opening polymerization of lipid-containing cyclic carbonate monomers and morpholinone monomers. Lipid variations of the CARTs substantially impacted the delivery efficiency of pDNA, with oleyl- and linoleyl-based CARTs showing enhanced performance relative to the commercial transfection agent Lipofectamine 2000 (L2000). The best-performing oleyl CART was carried forward to study stable luciferase transfection with a Sleeping Beauty (SB) transposon system. The oleyl CART outperformed the L2000 positive control with respect to stable transfection efficiency. CART-pDNA complexes represent a new DNA delivery system for research and clinical applications.</description><subject>BASIC BIOLOGICAL SCIENCES</subject><issn>1525-7797</issn><issn>1526-4602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNissKwjAQRYMo-PyH4EoXgdY2li5LVVyoi9K9pOmoIyGRTBT8ex_4Aa7O5dzTYYNYLpYiXUaL7ndLkWV51mdDomsURXmSygFTm7vVAZ1Vhq8OBV-BwQf4J19b1RhoefPkO7xhK_auxRO-TXlR_gyiMAE82jOvwICiT81rryzdnH8_xGdlUdU0H7PeSRmCyY8jNt2s63IrHAU8ksYA-qKdtaDDMZZ5Gmcy-St6ASNWRTY</recordid><startdate>20180504</startdate><enddate>20180504</enddate><creator>Benner, Nancy L.</creator><creator>Near, Katherine E.</creator><creator>Bachmann, Michael H.</creator><creator>Contag, Christopher H.</creator><creator>Waymouth, Robert M.</creator><creator>Wender, Paul A.</creator><general>American Chemical Society</general><scope>OIOZB</scope><scope>OTOTI</scope><orcidid>https://orcid.org/0000000163192829</orcidid><orcidid>https://orcid.org/0000000198629509</orcidid></search><sort><creationdate>20180504</creationdate><title>Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)</title><author>Benner, Nancy L. ; Near, Katherine E. ; Bachmann, Michael H. ; Contag, Christopher H. ; Waymouth, Robert M. ; Wender, Paul A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-osti_scitechconnect_15941753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>BASIC BIOLOGICAL SCIENCES</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benner, Nancy L.</creatorcontrib><creatorcontrib>Near, Katherine E.</creatorcontrib><creatorcontrib>Bachmann, Michael H.</creatorcontrib><creatorcontrib>Contag, Christopher H.</creatorcontrib><creatorcontrib>Waymouth, Robert M.</creatorcontrib><creatorcontrib>Wender, Paul A.</creatorcontrib><creatorcontrib>Stanford Univ., CA (United States)</creatorcontrib><collection>OSTI.GOV - Hybrid</collection><collection>OSTI.GOV</collection><jtitle>Biomacromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benner, Nancy L.</au><au>Near, Katherine E.</au><au>Bachmann, Michael H.</au><au>Contag, Christopher H.</au><au>Waymouth, Robert M.</au><au>Wender, Paul A.</au><aucorp>Stanford Univ., CA (United States)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)</atitle><jtitle>Biomacromolecules</jtitle><date>2018-05-04</date><risdate>2018</risdate><volume>19</volume><issue>7</issue><issn>1525-7797</issn><eissn>1526-4602</eissn><abstract>Safe and effective DNA delivery systems are required to enable or enhance clinical strategies and research involving gene therapy and DNA vaccinations. To address this delivery problem, a series of charge-altering releasable transporters (CARTs) with varied lipid content were prepared and evaluated for plasmid DNA (pDNA) delivery into cultured cells. These lipid-modified CART co-oligomers were synthesized in only two steps via sequential organocatalytic ring-opening polymerization of lipid-containing cyclic carbonate monomers and morpholinone monomers. Lipid variations of the CARTs substantially impacted the delivery efficiency of pDNA, with oleyl- and linoleyl-based CARTs showing enhanced performance relative to the commercial transfection agent Lipofectamine 2000 (L2000). The best-performing oleyl CART was carried forward to study stable luciferase transfection with a Sleeping Beauty (SB) transposon system. The oleyl CART outperformed the L2000 positive control with respect to stable transfection efficiency. CART-pDNA complexes represent a new DNA delivery system for research and clinical applications.</abstract><cop>United States</cop><pub>American Chemical Society</pub><orcidid>https://orcid.org/0000000163192829</orcidid><orcidid>https://orcid.org/0000000198629509</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-7797
ispartof Biomacromolecules, 2018-05, Vol.19 (7)
issn 1525-7797
1526-4602
language eng
recordid cdi_osti_scitechconnect_1594175
source ACS Publications
subjects BASIC BIOLOGICAL SCIENCES
title Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A12%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-osti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20DNA%20Delivery%20Enabled%20by%20Lipid-Modified%20Charge-Altering%20Releasable%20Transporters%20(CARTs)&rft.jtitle=Biomacromolecules&rft.au=Benner,%20Nancy%20L.&rft.aucorp=Stanford%20Univ.,%20CA%20(United%20States)&rft.date=2018-05-04&rft.volume=19&rft.issue=7&rft.issn=1525-7797&rft.eissn=1526-4602&rft_id=info:doi/&rft_dat=%3Costi%3E1594175%3C/osti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true